Flagship Biotech International Private Limited, a active private limited company, was established on 09 August 2011 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74120MH2011PTC220700. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.08 Cr and a paid-up capital of ₹1.33 M.
It upholds a compliant status. Employing 99 professional, Its leadership includes Shailesh Dilipbhai Patel (Director), Tejaswini Kedar Vidwans (Director), Kedar Avinash Vidhwans (Director). Past directors included Prema Jesuwin Cherian, Jesuwin Agnal Kalampukattuserry Cherian. It holds ₹59.67 Cr open charges and ₹8.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No 1302, 13Th Floor, Plot No A1, Sector 1, Millennium Business Park, Mahape, Navi Mumbai, Maharashtra, 400710.
U74120MH2011PTC220700
220700
09 August 2011
₹1.08 Cr
₹1.33 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Flagship Biotech International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Dilipbhai Patel | Director | 09 Aug 2011 | Current |
| Tejaswini Kedar Vidwans | Director | 09 Aug 2011 | Current |
| Kedar Avinash Vidhwans | Director | 09 Aug 2011 | Current |
| Dipaben Shailesh Patel | Director | 09 Aug 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jul 2021 | Past |
| Pramod Abcsdd | Director | 16 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Flagship Biotech International Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.2% decrease. The company also saw a slight improvement in profitability, with a 2.37% increase in profit. The company's net worth Soared by an impressive increase of 18.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Flagship Biotech International had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹596,670,000.00
₹86,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2025 | Axis Bank Limited | ₹20.00 Cr | Open |
| 11 Nov 2024 | Others | ₹10.00 Cr | Open |
| 11 Nov 2024 | Others | ₹15.00 Cr | Open |
| 30 Sep 2024 | Others | ₹10.00 Cr | Open |
| 30 Sep 2024 | Others | ₹6.67 M | Open |
Explore comprehensive loan charge details -
Flagship Biotech International has a workforce of 99 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Flagship Biotech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flagship Biotech International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 10.00 Cr registered on 11 Nov 2024 with Charge ID 101007712 was modified on 03 May 2025. was recorded as a recent event.
Progress on A charge with Others of Rs. 15.00 Cr registered on 11 Nov 2024 with Charge ID 101007711 was modified on 03 May 2025. was documented.
The activity A charge with Others of Rs. 10.00 Cr registered on 30 Sep 2024 with Charge ID 100984237 was modified on 03 May 2025. was completed.
A charge with Others of Rs. 0.67 Cr registered on 30 Sep 2024 with Charge ID 100984232 was modified on 03 May 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 20.00 Cr with Charge ID 101076212 was registered on 26 Mar 2025. was completed.
Progress on A charge with Axis Bank Limited of Rs. 4.00 Cr registered on 28 Aug 2018 with Charge ID 100206588 was modified on 26 Mar 2025. was documented.
The CIN of Flagship Biotech International Private Limited is U74120MH2011PTC220700.
Flagship Biotech International Private Limited is headquartered at Office No 1302, 13Th Floor, Plot No A1, Sector 1, Millennium Business Park, Mahape, Navi Mumbai, Maharashtra, 400710.
Flagship Biotech International Private Limited was incorporated on 09 August 2011.
The current directors of Flagship Biotech International Private Limited are
The primary industry of Flagship Biotech International Private Limited is Trade.
Flagship Biotech International Private Limited is unlisted.
The authorized capital of Flagship Biotech International Private Limited is ₹1.08 Cr, and the paid-up capital is ₹1.33 M.
The compliance status of Flagship Biotech International Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX